Quarterly report pursuant to Section 13 or 15(d)

FINANCIAL INSTRUMENTS AND SIGNIFICANT CONCENTRATIONS (Tables)

v3.24.0.1
FINANCIAL INSTRUMENTS AND SIGNIFICANT CONCENTRATIONS (Tables)
6 Months Ended
Dec. 31, 2023
FINANCIAL INSTRUMENTS AND SIGNIFICANT CONCENTRATIONS  
Schedule of financial assets measured at fair value on a recurring basis

The following table presents information about the Company’s financial assets measured at fair value on a recurring basis and indicates the fair value hierarchy classification of such fair values as of December 31, 2023 and June 30, 2023 (in thousands):

Fair Value Measurement of Assets as of December 31, 2023

Total

Level 1

Level 2

Level 3

Cash and cash equivalents:

Money market funds

$

5,272

$

5,272

$

$

U.S. Government treasuries

3,500

3,500

Corporate commercial paper

1,990

1,990

Marketable debt securities:

Corporate commercial paper

32,752

32,752

U.S. Government agencies

18,749

18,749

U.S. Government treasuries

997

997

Corporate notes and bonds

27,596

27,596

Asset-backed securities

3,352

3,352

Total

$

94,208

$

11,759

$

82,449

$

Fair Value Measurement of Assets as of June 30, 2023

Total

Level 1

Level 2

Level 3

Cash and cash equivalents:

Money market funds

$

5,464

$

5,464

$

$

Corporate commercial paper

4,481

4,481

Marketable debt securities:

Corporate commercial paper

41,597

41,597

U.S. Government agencies

26,394

26,394

U.S. Government treasuries

10,404

10,404

Corporate notes and bonds

19,240

19,240

Asset-backed securities

4,694

4,694

Total

$

112,274

$

20,349

$

91,925

$

-

Summary of changes in the fair value of the company's derivative liabilities, fair value, level 3 inputs The following table sets forth changes in the fair value of the Company’s embedded derivative liability for the six months ended December 31, 2023 and 2022 (in thousands):

2023

 

2022

Fair value, beginning of period

$

412

$

407

Loss from change in fair value

27

26

Fair value, end of period

$

439

$

433